about
Underrepresentation of Women and Minorities in the United States IR Academic Physician Workforce.Attracting Future Radiation Oncologists: An Analysis of the National Resident Matching Program Data Trends From 2004 to 2015.A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)The impact of stool and gas volume on intrafraction prostate motion in patients undergoing radiotherapy with daily endorectal balloon.End-of-radiation PSA as a novel prognostic factor in patients undergoing definitive radiation and androgen deprivation therapy for prostate cancerEsthesioneuroblastoma (olfactory neuroblastoma) with hemorrhage: an unusual presentationImproving diversity, inclusion, and representation in radiology and radiation oncology part 1: why these matterA case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate cancer.Retroperitoneal sarcoma (RPS) high risk gross tumor volume boost (HR GTV boost) contour delineation agreement among NRG sarcoma radiation and surgical oncologists.Retroperitoneal Sarcoma Target Volume and Organ at Risk Contour Delineation Agreement Among NRG Sarcoma Radiation Oncologists.Out-of-pocket expenses and treatment choice for men with prostate cancer.African American men with low-grade prostate cancer have increased disease recurrence after prostatectomy compared with Caucasian men.Current status of diversity by race, Hispanic ethnicity, and sex in diagnostic radiology.Treatment Guidelines for Preoperative Radiation Therapy for Retroperitoneal Sarcoma: Preliminary Consensus of an International Expert Panel.The effect of anterior proton beams in the setting of a prostate-rectum spacer.Female Representation in the Academic Oncology Physician Workforce: Radiation Oncology Losing Ground to Hematology Oncology.Trends in Disclosures of Industry Sponsorship.Improving diversity, inclusion, and representation in radiology and radiation oncology part 2: challenges and recommendations.Close to Home: Employment Outcomes for Recent Radiation Oncology Graduates.Sociodemographic disparities in the utilization of proton therapy for prostate cancer at an urban academic center.Disparities in staging prostate magnetic resonance imaging utilization for nonmetastatic prostate cancer patients undergoing definitive radiation therapy.Effect of Eischens Yoga During Radiation Therapy on Prostate Cancer Patient Symptoms and Quality of Life: A Randomized Phase II Trial.A prospective study of proton reirradiation for recurrent and secondary soft tissue sarcoma.Phase 1 Trial of Everolimus and Radiation Therapy for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following Prostatectomy.Diversity, Inclusion, and Representation: It Is Time to Act.Counterpoint: Diversity and Inclusion: Works in Progress.Adjuvant radiation therapy for bladder cancer: a dosimetric comparison of techniques.Acute gastrointestinal and genitourinary toxicity of image-guided intensity modulated radiation therapy for prostate cancer using a daily water-filled endorectal balloon.Discordance between preoperative and postoperative bladder cancer location: implications for partial-bladder radiation.Should image rotation be addressed during routine cone-beam CT quality assurance?Diversity in Graduate Medical Education in the United States by Race, Ethnicity, and Sex, 2012.Industry Funding Among Leadership in Medical Oncology and Radiation Oncology in 2015.Diversity by race, Hispanic ethnicity, and sex of the United States medical oncology physician workforce over the past quarter century.Prospective preference assessment of patients' willingness to participate in a randomized controlled trial of intensity-modulated radiotherapy versus proton therapy for localized prostate cancer.Bladder cancer patterns of pelvic failure: implications for adjuvant radiation therapy.The pervasive crisis of diminishing radiation therapy access for vulnerable populations in the United States, part 1: African-American patients.Development and clinical implementation of a universal bolus to maintain spot size during delivery of base of skull pencil beam scanning proton therapy.Diversity based on race, ethnicity, and sex, of the US radiation oncology physician workforce.Effect of intrafraction prostate motion on proton pencil beam scanning delivery: a quantitative assessment.Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.
P50
Q30276045-E746635A-E319-48C0-B922-15376320A54AQ31003972-6F7D1505-DDA2-4675-A8AD-C7A15B14E166Q32173730-24852F13-CA39-4781-BC28-35272BF21677Q33462253-FBF3D29D-A3B3-4D8F-A1B4-F121A63DDD8FQ33676155-82223A43-9872-4F73-B87C-D5E448AE2E44Q35062257-23E69DF9-8BF7-445E-AF4F-BF6B8AC9EC7CQ35096175-1F8EF383-5D0E-42E4-ABC9-47B63634EEB3Q35202412-20A899CD-B8BE-48DB-9575-53F5B0081249Q36384597-971A29F8-6778-4FBF-8646-B84B25A8E723Q36384616-0FA267FB-DDBB-434C-BF2D-F505F1F11DCBQ36502623-C7B0F260-5F09-4FEA-9648-96FE62683623Q37167067-A5CCB9EC-DB82-4475-907E-E6046D9184E6Q38125438-C6E36DAD-0C5F-4617-9121-A4F70FFCB71AQ38525915-E91329B1-26F4-4FB7-8935-3B9576F99943Q38548789-4B446EF4-888E-4BEC-B1C6-9EB03FEF8DDFQ38674150-92DA32FB-3CA6-45A4-BB2E-D39849ADEA32Q38873606-06608ADC-2E75-4357-A115-6AC789257DD7Q39149353-86DBE8F6-E958-461F-B208-85B26FEB734BQ39682972-9AF589EE-45E9-46C4-8C55-7B72491CB8C7Q40109681-494CB4EE-0BA7-4B42-B232-5906CDA1B48DQ40109688-DD9BE98E-9285-4F22-A56B-2CC29578FFA1Q40117369-77B83920-BF37-4C41-8900-2C87DDA46589Q40139318-B1427CAB-D5E7-4D46-98E7-5DD56534B719Q40420838-7BFE0EC4-4806-4795-82E8-F381B9626144Q40506813-DCC92FD9-1050-4796-A273-2AB2EC4EE7BFQ40792222-CD07A25C-3379-4148-9A15-6D3E1BEA7BAEQ41437225-D7EE1D3A-3A9E-4CAE-871D-D12FAA909067Q42129004-FCD38823-2C4C-4E19-B29B-3851B50262D9Q43765417-12CCD5D5-50EC-4AC8-A123-1C5DC9C82313Q43790074-6C3A6C59-E7E8-4039-B495-02F435064051Q44446330-4F6E5041-8264-4B55-8EE9-444BBD2A8427Q46169825-E1A58F39-0523-4EA2-82FD-D3E74B0D0FBEQ46595012-4C5202E6-FB95-4FD9-AD2D-627A003A7641Q46738659-9979B31E-F719-4943-84AF-A4D0683BFE44Q46915263-5D60EAD0-9C1A-49C0-9EE7-91932B317E54Q47131493-9CBF3330-04D3-49B9-90D0-396358C26406Q47438257-AFF970CC-090F-48A5-8852-ECC3877BD2D5Q47817050-DA11C871-085F-4C4E-BA01-7BA7BA8D3FA9Q48713645-9F8E3FC4-FC8A-40A8-8C27-14A4591DF8F9Q51735864-817B0F24-9BDD-44A8-A95A-33680D2F693B
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Curtiland Deville
@ast
Curtiland Deville
@en
Curtiland Deville
@es
Curtiland Deville
@nl
Curtiland Deville
@sl
type
label
Curtiland Deville
@ast
Curtiland Deville
@en
Curtiland Deville
@es
Curtiland Deville
@nl
Curtiland Deville
@sl
prefLabel
Curtiland Deville
@ast
Curtiland Deville
@en
Curtiland Deville
@es
Curtiland Deville
@nl
Curtiland Deville
@sl
P1053
B-2819-2013
P106
P21
P31
P3829
P3835
curtiland-deville
P496
0000-0003-4846-6486